STONKWHISPER
← Back to Intel
Insider ActivityVRDN

Fairmount Funds Management LLC, Director, 10% Owner at Viridian Therapeutics, Inc.\DE, bought $20.0M of VRDN

Updated Jun 12, 2026
Fairmount Funds Management LLC Director, 10% Owner
Viridian Therapeutics, Inc.\DE · $VRDN
$20.0M Total Value
1,176,470 Shares Traded
$17 Price / Share
5,090,928 Shares Owned After
2026-05-13 Filing Date

Transaction Details

InsiderFairmount Funds Management LLC
TitleDirector, 10% Owner
CompanyViridian Therapeutics, Inc.\DE
TickerVRDN
Transaction TypePurchase
Transaction Date2026-05-11
Shares Traded1,176,470
Price Per Share$17
Total Value$20.0M
Filed Date2026-05-13
Accession Number0001104659-26-060294

Ownership Context

Shares Owned After Transaction5,090,928
Ownership TypeIndirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001104659-26-060294

Other Trades by Fairmount Funds Management LLC

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for VRDN — Viridian Therapeutics, Inc.\DE →

Track VRDN insider activity in real time on The Wire →

Get alerts when Fairmount Funds Management LLC files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 12, 2026 at 07:08 UTC

Want real-time data? Access The Wire for live sentiment tracking.